News in the Life Sciences Industry

Galderma extends its commitment to understanding the beyond the visible impact of rosacea with new patient insights supporting healthcare professionals' understanding of patient behavior and revealing possible motivations for not reconsulting

BEIJING, April 7, 2019 /PRNewswire/ -- Hope Medicine Inc. announced today that they have signed a world-wide exclusive license agreement with Bayer AG on the development and commercialization of a human antibody targeting the PRL receptor for the treatment of male and female pattern hair loss,... Read more ››

Phase 3 post-hoc analysis indicates less fentanyl and overall illicit opioid use for weekly/monthly buprenorphine depots versus daily standard treatment in a difficult to treat patient population

HONG KONG and MARTINSRIED, Germany and MUNICH, April 4, 2019 /PRNewswire/ -- Sinovant Sciences and Roivant Sciences today announced the launch of Cytovant Sciences, a biopharmaceutical company focused on developing and commercializing innovative cellular therapeutics in Asia. Cytovant will focus... Read more ››

- Those with no previous experience of colonoscopy were considerably more nervous about the procedure than those who had already undergone colonoscopy (74% vs 49%)

BURGWEDEL, Germany, April 4, 2019 /PRNewswire/ -- MYR Pharmaceuticals today announced that the final results of the MYR203 study of bulevirtide (Myrcludex), MYR's first-in-class entry inhibitor for treatment of hepatitis B and D infection, will be presented at the General Session of the upcoming... Read more ››

NURNBERG, Germany, April 4, 2019 /PRNewswire/ -- Alma, one of the top five global leaders of energy-based medical and aesthetic solutions, today announced global launch of BeautiFill, the first laser-assisted... Read more ››

OSAKA, Japan and LEVERKUSEN, Germany, April 2, 2019 /PRNewswire/ -- The Japanese pharmaceutical company Maruho Co., Ltd. intends to further expand its longstanding strategic partnership with the biotech company Biofrontera AG. Maruho made its first investment in Biofrontera in April 2013 and... Read more ››